IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

ENSAPHARMA LLP

LLPIN : ACU-6253|ROC: RoC-HyderabadActive
Last Updated On : 10-02-2026
LLPINACU-6253
LLP NameENSAPHARMA LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Hyderabad
Date of Incorporation22-01-2026
Registered AddressFT-820, SMR VINAY HI-LAND MADEENAGUDA Mathrusri Nagar K.V.Rangareddy Serilingampally Telangana India 500049
Email IDTEXTKCUBE@GMAIL.COM
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India46
Description of main divisionWHOLESALETRADE,EXCEPTOFMOTORVEHICLESANDMOTORCYCLES
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
08274545PENNAMAREDDY RAMESH22-01-2026
08274544SWARNA PRIYA PENNAMAREDDY22-01-2026
ENSAPHARMA LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Hyderabad, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 22-01-2026 and last updated on 10-02-2026. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, ENSAPHARMA LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is FT-820, SMR VINAY HI-LAND MADEENAGUDA Mathrusri Nagar K.V.Rangareddy Serilingampally Telangana India 500049. Correspondence or inquiries may be sent to the official email address, TEXTKCUBE@GMAIL.COM.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.